Referência de medicamentos
Galcanezumab
Galcanezumab is a medicine in the class central nervous system. It is used for cluster headache.
- Classe do medicamento: Central Nervous System
- Indicado para: cluster headache
Última atualização
Para profissionais de saúde — apenas referência. Esta página é um resumo breve, não é aconselhamento médico nem substitui a bula oficial ou o julgamento clínico. Verifique sempre antes de prescrever ou dispensar.
O conteúdo clínico desta página está disponível apenas em inglês.
Pontos-chave
- Classe do medicamento
- Central Nervous System
- Formas farmacêuticas comuns
- injeção
- Concentrações comuns
- 120 mg/ml, 100 mg/ml
- Interações conhecidas
- 3 (Moderada: 3)
- Nomes comerciais
- 5
- Países e mercados
- 5
Para que é usado
Como funciona
Humanized monoclonal antibody; binds to calcitonin gene-related peptide (CGRP) ligand and blocks its binding to the receptor
Dose habitual em adultos (resumo da bula)
Migraine Prophylaxis: Loading dose: 240 mg SC once (ie, 2 consecutive 120-mg SC injections), Maintenance dose: 120 mg SC monthly
Gravidez e amamentação
- Gravidez
- Unknown No adequate human data; no harm in rat and rabbit studies. As an IgG antibody it crosses the placenta, mainly late in pregnancy, and exposure continues for months after the last dose; a pregnancy registry exists. EU label: as a precaution, preferable to avoid in pregnancy.
- Amamentação
- Unknown No milk data. EU label: a risk cannot be excluded in the first days after birth; afterwards use only if clinically needed. LactMed: likely very low in milk and partly digested by the infant; use with caution, especially with a newborn or preterm infant.
Efeitos adversos relatados
- Injection site reactions
- Angioedema
Contraindicações
- Serious hypersensitivity to galcanezumab-gnlm or to any of the excipients.
Quem deve ter cuidado
- Hypersensitivity reactions (dyspnea, urticaria, rash; anaphylaxis and angioedema postmarketing) can occur, even days after administration, and may be prolonged. If a serious reaction occurs, discontinue and treat appropriately.
- Constipation with serious complications, including hospitalization and surgery, has been reported, usually after the first dose. Monitor for severe constipation; medications that reduce GI motility may increase the risk.
- New-onset or worsening hypertension has been reported, most often within 7 days of starting. Monitor blood pressure and consider discontinuation if no other cause is found or BP is inadequately controlled.
Informe ao farmacêutico ou ao médico sobre gravidez ou amamentação, doença renal ou hepática, alergias e todos os outros medicamentos ou suplementos que você usa.
Principais interações (3)
- Efgartigimod / hyaluronidase sc + Galcanezumab Moderate
- Efgartigimod alfa + Galcanezumab Moderate
- Galcanezumab + Rozanolixizumab Moderate
Para assinantes do Pro+
Desbloqueie a página completa
Crie uma conta e comece um teste do Pro+ para abrir a monografia completa de Galcanezumab: doses, gravidez e amamentação, efeitos adversos, advertências e todas as interações.
- Dosing by age, kidney and liver function, and further dose lines
- Paediatric dosing
- Patient counselling points
- Food interactions
Experimente o Pro+ grátis por 14 dias na web. Sem cartão.
Outros medicamentos desta classe
Perguntas frequentes
What is Galcanezumab used for?
Galcanezumab is a medicine in the class central nervous system. It is used for Cluster headache, Migraine.
What side effects have been reported with Galcanezumab?
Injection site reactions, Angioedema.
Can Galcanezumab be taken in pregnancy or while breastfeeding?
Pregnancy: Unknown. No adequate human data; no harm in rat and rabbit studies. As an IgG antibody it crosses the placenta, mainly late in pregnancy, and exposure continues for months after the last dose; a pregnancy registry exists. EU label: as a precaution, preferable to avoid in pregnancy. Breastfeeding: Unknown. No milk data. EU label: a risk cannot be excluded in the first days after birth; afterwards use only if clinically needed. LactMed: likely very low in milk and partly digested by the infant; use with caution, especially with a newborn or preterm infant.
What does Galcanezumab interact with?
MediHelp lists 3 known interactions for Galcanezumab. Moderate: 3. The most serious include Efgartigimod / hyaluronidase sc, Efgartigimod alfa, Rozanolixizumab.
Monografias completas, posologia e verificador de interações no app MediHelp
Abra a referência completa, verifique interações entre vários medicamentos e use as ferramentas de posologia no app MediHelp.
